Peraso Inc. Receives Nasdaq Noncompliance Notice; Sets 2026 Annual Meeting

What Happened
Peraso Inc. filed an 8-K on July 24, 2026 disclosing two material items: (1) Nasdaq’s Listing Qualifications Staff notified the company on July 21, 2026 that Peraso no longer meets the minimum $1 closing bid price requirement under Nasdaq Listing Rule 5550(a)(2) based on the 30 consecutive business days ended July 20, 2026; and (2) the board set the company’s 2026 Annual Meeting of Stockholders for September 10, 2026 (virtual), with a record date of July 20, 2026, and announced deadlines for shareholder proposals and director nominations.

Key Details

• Nasdaq notice dated July 21, 2026: Peraso has 180 calendar days (until January 19, 2027) to regain compliance by having a closing bid of at least $1.00 per share for at least ten consecutive business days.
• If not cured in the initial 180 days, Peraso may seek a second 180-day extension (by meeting other listing standards and notifying Nasdaq of intent to possibly effect a reverse stock split).
• Annual Meeting set for September 10, 2026 (virtual); stockholders of record as of July 20, 2026 may vote.
• Deadlines for shareholder actions: proposals under Rule 14a-8 and bylaw nomination notices must be received by the Company Secretary by 5:00 p.m. ET on August 3, 2026; notices to comply with universal proxy (Rule 14a-19) are also due by August 3, 2026.

Why It Matters
For investors, the Nasdaq notice signals a potential listing risk: if Peraso’s share price does not meet the $1 threshold within the specified cure periods (or via a reverse split), the stock could face delisting proceedings. The Annual Meeting and the August 3 proposal/nomination deadlines are important for shareholders who want to submit proposals or nominate directors—missing those dates will forfeit the ability to include matters or nominees in the company’s proxy process.